Taras, Pendatun G.
HRN: 04-14-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2024
CEFUROXIME 1.5GM (VIAL)
10/02/2024
10/09/2024
IV
1g
Q12
Decibitus Ulcer Sacral Area
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes